Lexicon Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.09.17	Technical Snapshots for These Biotech Stocks -- ZIOPHARM Oncology, Zosano Pharma, Juno Therapeutics, and Lexicon Pharma (PR Newswire)
05.09.17	Lexicon Pharmaceuticals to Present New Clinical Data at the European Association for the Study of Diabetes 53rd Annual Meeting (PR Newswire)
15.08.17	Lexicon Pharmaceuticals Reports Additional Positive Data From Pivotal Phase 3 inTandem2 Study Of Sotagliflozin (PR Newswire)
03.08.17	Lexicon Pharmaceuticals To Present At 2017 Wedbush PacGrow Healthcare Conference (PR Newswire)
01.08.17	Lexicon Pharmaceuticals Reports Second Quarter 2017 Financial Results And Provides A Business Update (PR Newswire)
24.07.17	Lexicon Pharmaceuticals To Host Second Quarter 2017 Financial Results Conference Call And Webcast On August 1, 2017 (PR Newswire)
24.07.17	One Step Closer To EU Approval... (RTTNews)
21.07.17	Lexicon Collaborator Ipsen Receives Positive CHMP Opinion For Xermelo® (Telotristat Ethyl) (PR Newswire)
07.07.17	Daily Technical Summary Reports on Biotech Stocks -- Juno Therapeutics, Lexicon Pharma, NantKwest, and Nektar Therapeutics (PR Newswire)
26.06.17	GB Sciences Wins Louisiana State University (LSU) Bid to Act as LSU Agricultural Center's Exclusive Operator of Medical Cannabis Production Facility (PR Newswire)
19.06.17	NCCN Guidelines For Neuroendocrine Tumors Include XERMELO In Combination With Somatostatin Analog Therapy As A Recommended Treatment Option For Patients With Carcinoid Syndrome Diarrhea (PR Newswire)
12.06.17	LXRX Brings Sweet Tidings, PFE's PROSPER Ahead Of Schedule, XBIT Fails To Excite (RTTNews)
10.06.17	Sotagliflozin Data from Pivotal inTandem1 and inTandem2 Studies in Patients with Type 1 Diabetes Presented at ADA 2017 (PR Newswire)
05.06.17	Lexicon Pharmaceuticals To Present New Clinical Data At 77th American Diabetes Association Scientific Sessions (PR Newswire)
31.05.17	Lexicon Pharmaceuticals To Present At Upcoming Investor Conferences (PR Newswire)
11.05.17	Lexicon Pharmaceuticals Reports Additional Positive Data From Pivotal InTandem1 Phase 3 Study For Sotagliflozin In Patients With Type 1 Diabetes (PR Newswire)
04.05.17	Lexicon Pharmaceuticals To Present At The Bank Of America Merrill Lynch 2017 Healthcare Conference (PR Newswire)
02.05.17	Lexicon Pharmaceuticals Reports First Quarter 2017 Financial Results And Provides A Business Update (PR Newswire)
28.04.17	Lexicon Pharmaceuticals To Host First Quarter 2017 Financial Results Conference Call And Webcast On May 2, 2017 (PR Newswire)
05.04.17	Biotech Stocks on Investors' Radar -- Puma Biotechnology, Regeneron Pharma, Calithera, and Lexicon Pharma (PR Newswire)
03.04.17	Lexicon To Present At The 16th Annual Needham Healthcare Conference (PR Newswire)
09.03.17	Lexicon To Present At The Barclays Global Healthcare Conference (PR Newswire)
06.03.17	Lexicon To Present At The Cowen And Company 37th Annual Healthcare Conference (PR Newswire)
03.03.17	Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 Fourth Quarter And Full Year Financial Results (PR Newswire)
01.03.17	AKRX, LXRX Get FDA Nod, KITE Flies Higher, SRPT Plunges On Dull Outlook (RTTNews)
01.03.17	FDA Approves Lexicon's Xermelo For Carcinoid Syndrome Diarrhea (RTTNews)
28.02.17	FDA Approves Lexicon Drug XERMELO™ (telotristat ethyl) 250 mg As First And Only Oral Treatment For Carcinoid Syndrome Diarrhea In Cancer Patients With Metastatic Neuroendocrine Tumors (PR Newswire)
13.02.17	Lexicon To Present At The Leerink Partners 6th Annual Global Healthcare Conference (PR Newswire)
02.02.17	Research Reports Coverage on Biotech Stocks -- Anavex Life Sciences, Omeros, Spectrum Pharma, and Lexicon Pharma (PR Newswire)
09.01.17	Lexicon Begins Phase 1 Clinical Trial Of Locally-acting SGLT1 Inhibitor, LX2761, For Potential Treatment Of Diabetes (PR Newswire)
27.12.16	Research Reports Initiation on Biotech Stocks -- Progenics Pharma, Tokai Pharma, Ophthotech, and Lexicon Pharma (PR Newswire)
21.12.16	Lexicon Reports Positive Top-line Results In Second Pivotal Phase 3 Study For Sotagliflozin In Patients With Type 1 Diabetes (PR Newswire)
06.12.16	MÄRKTE USA/Nach Italien wartet Wall Street auf nächsten Impuls (Dow Jones)
06.12.16	MÄRKTE USA/Wall Street auf der Suche nach Impulsen (Dow Jones)
06.12.16	MARKT USA/Wall Street auf der Suche nach Impulsen (Dow Jones)
05.12.16	Lexicon Reports Top-Line Results From Phase 2 Clinical Trial Conducted In Collaboration With JDRF (PR Newswire)
21.11.16	Lexicon Announces The Establishment Of The Commercial Leadership Team For Telotristat Ethyl (PR Newswire)
09.09.16	MÄRKTE USA/Wall Street mit grösstem Absturz seit Brexit-Votum (Dow Jones)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Lexicon Pharmaceuticals Inc

Aktien Top/Flop

Meistgelesene Nachrichten